Glenmark Recalls Clobetasol Propionate Foam Due to Defective Delivery System
Glenmark Pharmaceuticals is recalling Clobetasol Propionate Foam because the product is not foaming or is coming out as liquid.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a functional defect in the delivery system rather than a contamination or safety hazard.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling Clobetasol Propionate Foam, 0.05%, in 50 g and 100 g packs. The recall is due to a defective delivery system where the product is not foaming or is coming out as liquid.
The affected product is a prescription-only topical medication manufactured by Glenmark Pharmaceuticals Ltd. in India for Glenmark Pharmaceuticals Inc. in the USA. The recall covers specific lot numbers with expiration dates ranging from February 2021 to July 2021.
Consumers with this product should stop using it and contact their healthcare provider or pharmacist for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)
- Brand
- CLOBETASOL PROPIONATE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Topical Steroid
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- a) 14190026
- 14190028
- 14190029
- exp Feb-2021
- 14190043
- 14190045 exp Apr-2021 b) 14190024
- 14190025
- 14190027
- 14190030
- 14190031
- exp Mar-2021
- 14190039
- 14190042 exp Apr-2021
- 14190047 exp May-2021
- 14190062 exp Jul-2021
UPCs (1)
- 0368462608944
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Glenmark Pharmaceuticals Inc., USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · CLOBETASOL PROPIONATE
- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- ModerateClobetasol Propionate Cream recalled due to subpotent drug
FDA (Drugs) · 2023-02-01
- SevereClobetasol Propionate Ointment Recalled for Microbial Contamination
FDA (Drugs) · 2022-01-19
- LowGlenmark Recalls Clobetasol Propionate Foam Due to Defective Delivery System
FDA (Drugs) · 2019-12-18
- LowOxalis Labs Recalls Clobetasol Propionate Topical Solution Due to Leakage
FDA (Drugs) · 2019-02-20
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · defective delivery system
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- HighAIRSUPRA Albuterol and Budesonide Inhalation Aerosol Recalled for Defective Delivery System
FDA (Drugs) · 2025-05-28
- HighLorazepam Oral Syringes Recalled Due to Defective Delivery System Causing Leakage
FDA (Drugs) · 2025-03-12
- ModerateVarithena Administration Pack Recalled Due to Incorrect Syringe Connector Type
FDA (Drugs) · 2024-12-18
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29